A detailed history of Nisa Investment Advisors, LLC transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 346 shares of MORF stock, worth $10,822. This represents 0.0% of its overall portfolio holdings.

Number of Shares
346
Previous 316 9.49%
Holding current value
$10,822
Previous $9,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$26.64 - $40.31 $799 - $1,209
30 Added 9.49%
346 $12,000
Q4 2023

Jan 25, 2024

SELL
$19.95 - $31.0 $16,718 - $25,978
-838 Reduced 72.62%
316 $9,000
Q2 2023

Aug 11, 2023

SELL
$34.33 - $62.11 $5,836 - $10,558
-170 Reduced 12.84%
1,154 $66,000
Q3 2022

Nov 07, 2022

BUY
$22.23 - $33.37 $533 - $800
24 Added 1.85%
1,324 $37,000
Q2 2022

Aug 03, 2022

BUY
$19.74 - $43.01 $25,661 - $55,913
1,300 New
1,300 $28,000

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $1.2B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.